sh-vector-shutterstock-com-1
SH-Vector / Shutterstock.com
10 September 2015PharmaClaire Phipps-Jones

London calling: the benefits of the UPC’s new home

The announcement on August 11 of the location of the London central division of the Unified Patent Court (UPC) should be welcomed by the life sciences sector. Not only is the new court at Aldgate Tower in the middle of legal London and a stone’s throw from MedCity (the organisation managing a life sciences cluster including London, Cambridge and Oxford), it’s also easily accessible to the hotbed of innovators and manufacturers based in London and the south-east and to international court users alike.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Pharma
10 September 2026   Four patents stood firm in a Johnson & Johnson unit’s fight with Sandoz, leaving the generics maker facing a lengthy wait before its esketamine nasal spray can reach the US market.
Pharma
7 September 2026   A single phrase in a patent has proved decisive in Biofer’s infringement fight with Vifor, with the Federal Circuit exposing the risks of small claim-drafting choices for life sciences companies.
Pharma
27 August 2026   Turkish regulators are investigating the drugmaker over its efforts to protect its drug from generic rivals—conduct that may sound familiar to European competition watchers.